CancerAndCare_hero
shape-element-one[1]
shape-element-two[1]

Cancer and the CARE Program®

Ambry’s CARE program can help identify individuals at increased risk for cancer and/or who qualify for hereditary cancer testing, offering support for healthcare providers and their patients at every step.

Identify High-Risk Patients

Our CARE Program helps healthcare providers find patients at increased cancer risk or who qualify for genetic testing, so no one gets missed. Customized cancer screening and risk reduction plans can then be made, with the goal of earlier detection and decreased cancer risks. Educational resources and support for patients and healthcare providers are available to support the entire process.

CARE’s award-winning approach utilizes a secure HIPAA-compliant platform to collect and analyze patients’ medical information and family history prior to in-person visits. This can be used to identify individuals at increased risk for cancer and/or who qualify for hereditary cancer testing in their patient population.

In the Hospital, Portrait Shot of Topless Female Patient Undergoing Mammogram Screening Procedure. Healthy Young Female Does Cancer Preventive Mammography Scan.

Breast Cancer Risk Assessment

The CARE Program’s evidence-based digital tools analyze medical and family history information to assess and provide a patient’s lifetime risk of developing breast cancer. If that risk is 20%[1] or higher, increased breast cancer screening, including annual breast MRI, may be appropriate. The aim is to detect breast cancer earlier, when it is more treatable. In some cases, risk-reducing options may be appropriate based on the lifetime cancer risk.

1. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR, Monticciolo, Debra L. et al., Journal of the American College of Radiology, Volume 15, Issue 3, 408 – 414

Excited American family signing the agreement on buying a house

Hereditary Cancer Testing

Using a patient’s medical history, family history, and previous genetic results, CARE analyzes this against published national guidelines to determine if a patient meets criteria for hereditary cancer testing. Accessing genetic testing for high-risk patients enables them to explore increased cancer screening, risk-reducing options medications, or surgical procedures as appropriate for their results. This information can also help at-risk relatives, who may qualify for genetic testing.

Doctor at the hospital talking to a patient in the waiting room
Healthcare Providers
  • Consistently collect and analyze patient medical and family history
  • Enable patient education and informed consent
  • Identify patients and families who qualify for hereditary cancer testing
  • Implement tailored cancer screening and risk reduction plans that are guideline-concordant
Women’s Medical Appointment
Patients
  • Access resources to understand your cancer risks and genetic testing options
  • Genetic counseling is available to discuss your genetic test results
  • Customize cancer screening and plans to reduce your risks
  • Learn if family members may also be at risk

How Does CARE Work?

care-cancer-01-identification-01a

Identification

Using digital tools to collect/analyze patient health data
care-cancer-02-pre-test-education-01a

Pre-Test Education

Demonstrating how genetic testing can guide health and family planning and prenatal care
care-cancer-03-genetic-testing-01a

Genetic Testing

Streamlining ordering through Ambry for qualified individuals
care-cancer-04-results-delivery-01a

Results Delivery

Delivering results to the ordering provider and next steps for patients, including customizable options for patient result disclosure
care-cancer-05-post-test-genetic-counseling-01a

Post-Test Genetic Counseling

Making telehealth-based genetic counseling available to all patients after testing, at no charge to patient
care-cancer-06-documentation-01a

Documentation

Improving patient and provider experience with transparency at each step